These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11105302)

  • 1. [Total magnesium in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis].
    Iłzecka J; Stelmasiak Z; Kot A
    Neurol Neurochir Pol; 2000; 34(4):699-706. PubMed ID: 11105302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential trace element alterations in amyotrophic lateral sclerosis.
    Kapaki E; Zournas C; Kanias G; Zambelis T; Kakami A; Papageorgiou C
    J Neurol Sci; 1997 Apr; 147(2):171-5. PubMed ID: 9106124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace elements, age, and sex in amyotrophic lateral sclerosis disease.
    Kanias GD; Kapaki E
    Biol Trace Elem Res; 1997 Feb; 56(2):187-201. PubMed ID: 9164664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free amino acid levels in amyotrophic lateral sclerosis.
    Patten BM; Harati Y; Acosta L; Jung SS; Felmus MT
    Ann Neurol; 1978 Apr; 3(4):305-9. PubMed ID: 666270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.
    Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R
    Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
    Iłzecka J; Stelmasiak Z; Dobosz B
    Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H
    Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
    J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis.
    Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M
    Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid detection of enterovirus genome in ALS: a study of 242 patients and 354 controls.
    Vandenberghe N; Leveque N; Corcia P; Brunaud-Danel V; Salort-Campana E; Besson G; Tranchant C; Clavelou P; Beaulieux F; Ecochard R; Vial C; Broussolle E; Lina B
    Amyotroph Lateral Scler; 2010 May; 11(3):277-82. PubMed ID: 19900148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.